Tokyo, Sept. 17 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059096) titled 'Evaluation Study of Motor and Cognitive Dual-Task Effects in Mild Stroke Patients' on Sept. 16.
Study Type:
Observational
Primary Sponsor:
Institute - Reiwa Rehabilitation Hospital, Chinseikai Medical Corporation
Condition:
Condition - stroke
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To classify patients with mild stroke based on the levels of motor dual-task interference and cognitive dual-task interference, and to clarify the clinical characteristics of each subgroup.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 60
years-old
=
Gender - Male and Female
Key inclusion criteria - (1) the ability to walk independently or under supervision on level indoor surfaces
(2) a score of 21 on the lower extremity subscale of the Fugl-Meyer Assessment
Key exclusion criteria - (1) difficulty understanding tasks due to aphasia or severe attentional deficits
(2) severe paralysis or orthopedic conditions that significantly limited walking ability
(3) severe visual or hearing impairments
Target Size - 60
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2023 Year 04 Month 01 Day
Date of IRB - 2023 Year 03 Month 30 Day
Anticipated trial start date - 2023 Year 06 Month 01 Day
Last follow-up date - 2025 Year 05 Month 15 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067601
Disclaimer: Curated by HT Syndication.
